Janney Montgomery Scott LLC

Position in CADL — Candel Therapeutics, Inc.

CIK 1329948 PHILADELPHIA, PA

Position in CADL

as of Mar 31, 2026 · filed Apr 22, 2026 Compact

Position Value

$149,312

-$3,644 QoQ

Shares Held

30,472

+12.6% QoQ

Ownership

0.042%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2024

8 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Janney Montgomery Scott LLC holds $101,269,363 across 48 Biotechnology names. CADL ranks #40 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	84,324	$37,654,038
2	SPRY	ARS Pharmaceuticals, Inc.	2,016,464	$16,192,205
3	REGN	Regeneron Pharmaceuticals, Inc.	13,078	$10,104,585
4	INCY	Incyte Corp	55,431	$5,217,165
5	ALNY	Alnylam Pharmaceuticals, Inc.	9,339	$3,089,994
6	ZVRA	Zevra Therapeutics, Inc.	236,834	$2,207,292
7	INVA	Innoviva, Inc.	90,000	$2,097,000
8	AXSM	Axsome Therapeutics, Inc.	12,030	$2,033,310

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$149,312	30,472	+12.6%	Shares	Sole	2026-04-22
2025-12-31	$152,956	27,072	-10.9%	Shares	Sole	2026-02-11
2025-09-30	$154,968	30,386	+11.3%	Shares	Sole	2025-10-27
2025-06-30	$138,087	27,290	+29.4%	Shares	Sole	2025-07-17
2025-03-31	$119,158	21,090	+104.3%	Shares	Sole	2025-04-17
2024-12-31	$89,621	10,325	-11.5%	Shares	Sole	2025-01-17
2024-09-30	$80,838	11,665	+0.4%	Shares	Sole	2024-10-29
2024-06-30	$72,013	11,615	—	Shares	Sole	2024-07-25
No filing history on record for this holder in this stock.